Epidermal growth factor receptor (EGFR) mutations are the most frequent type of mutation in NSCLC patients, with approximately 30% of NSCLC patients carrying EGFR mutations [5]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.